Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-25

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Physical and Psychologic Effects of Aromatherapy in Cancer Patients During Chemotherapy

NCT04826601

Pain Heart Rate Variability Anxiety

UNKNOWN NA

Aromatherapy Applied to Intensive Care Nurses Effect on Fatigue and Sleep Quality

NCT06474793

Aromatherapy

RECRUITING NA

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

NCT05282706

Suffering, Physical Nausea

ENROLLING_BY_INVITATION PHASE1

Breathing Interventions for Relaxation: Dosing Through Extended Exhale

NCT02870868

Healthy Adults Stress

COMPLETED NA

Effect of Agarwood (Aquilaria Sinensis) Inhalation Aromatherapy on Workplace Fatigue and Sleep Quality Among Hospital Employees: A Randomized Controlled Trial

NCT07188831

Fatigue Occupational Stress or Workplace Stress Sleep Quality

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Inclusion criteria

1. Over 20 years old.
2. It is determined by the physician to meet the final diagnosis conditions.
3. Symptoms of dyspnea.
4. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points.
5. Able to communicate in Mandarin or Taiwanese or written conversation.
6. Unconscious disorder.
7. After explaining and explaining, agree to participate in this research and sign the consent form.

Exclusion criteria

1. Receive treatment for facial trigeminal nerve damage.
2. Abnormal sense of smell.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breathlessness Aromatherapy Fans Terminal Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Over 20 years old.
2. It is determined by the physician to meet the final diagnosis conditions.
3. Symptoms of dyspnea.
4. The status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (ECOG) ≧ 2 points.
5. Able to communicate in Mandarin or Taiwanese or written conversation.
6. Conscience clear.
7. After explaining and explaining, agree to participate in this research and sign the consent form.